Feltl & Co Upgrades ResMed (RMD) to Buy
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $231.52 +1.35%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
Feltl & Co upgraded ResMed (NYSE: RMD) from Hold to Buy, price target raised from $33.15 to $38.00.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $32.05 yesterday.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $32.05 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Apollo Tyres (APTY:IN) to Buy
- OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB147.60 at Macquarie
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
